Left Ventricular Systolic Dysfunction (Disorder) Clinical Trial
Artificial Intelligence-assisted Diagnosis and Prognostication in Low Ejection Fraction Using Electrocardiograms
This is a randomized controlled trial (RCT) to test a novel artificial intelligence (AI)-enabled electrocardiogram (ECG)-based screening tool for improving the diagnosis and management of left ventricular systolic dysfunction.
|Source||National Defense Medical Center, Taiwan|
|Status||Not yet recruiting|
|Start date||November 16, 2021|
|Completion date||December 31, 2023|